Abstract
Thymoquinone (TQ) is a highly perspective chemotherapeutic agent against gliomas and glioblastomas because of its ability to cross the blood–brain barrier and its selective cytotoxicity for glioblastoma cells compared to primary astrocytes. Here, we tested the hypothesis that TQ-induced mild oxidative stress provokes C6 glioma cell apoptosis through redox-dependent alteration of MAPK proteins. We showed that low concentrations of TQ (20–50 μM) promoted cell-cycle arrest and induced hydrogen peroxide generation as a result of NADH-quinone oxidoreductase 1-catalyzed two-electron reduction of this quinone. Similarly, low concentrations of TQ efficiently conjugated intracellular GSH disturbing redox state of glioma cells and provoking mitochondrial dysfunction. We demonstrated that high concentrations of TQ (70–100 μM) induced reactive oxygen species generation due to its one-electron reduction. TQ provoked apoptosis in C6 glioma cells through mitochondrial potential dissipation and permeability transition pore opening. The identified TQ modes of action on C6 glioma cells open up the possibility of considering it as a promising agent to enhance the sensitivity of cancer cells to standard chemotherapeutic drugs.
Similar content being viewed by others
References
Delgado-Lopez PD, Corrales-Garcıa EM (2016) Survival in glioblastoma: a review on the impact of treatment modalities. Clin Transl Oncol 18(11):1062–1071. https://doi.org/10.1007/s12094-016-1497-x
Jungk C, Chatziaslanidou D, Ahmadi R, Capper D, Bermejo JL (2016) Chemotherapy with BCNU in recurrent glioma: analysis of clinical outcome and side effects in chemotherapy-naive patients. BMC Cancer 16:81. https://doi.org/10.1186/s12885-016-2131-6
Khosla D (2016) Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma. Ann Transl Med 4:54. https://doi.org/10.3978/j.issn.2305-5839.2016.01.25
Haar CP, Hebbar P, Wallace GC et al (2012) Drug resistance in glioblastoma: a mini review. Neurochem Res 37:1192–1200. https://doi.org/10.1007/s11064-011-0701-1
Yan Y, Xu Z, Dai S (2016) Targeting autophagy to sensitive glioma to temozolomide treatment. J Exp Clin Cancer Res 35:23. https://doi.org/10.1186/s13046-016-0303-5
Saify ZS, Mushtaq N, Noor F, Takween S, Arif M (1999) Role of quinone moiety as antitumour agents: a review. Pak J Pharm Sci 12(2):21–31
Lamson DW, Plaza SM (2003) The anticancer effects of vitamin K. Altern Med Rev 8(3):303–318
Darakhshan S, Bidmeshki PA, Hosseinzadeh CA, Sisakhtnezhad S (2015) Thymoquinone and its therapeutic potentials. Pharmacol Res 95–96:138–158. https://doi.org/10.1016/j.phrs.2015.03.011
Racoma IO, Meisen WH, Wang QE, Kaur B, Wani AA (2013) Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells. PLoS ONE 8(9):e72882. https://doi.org/10.1371/journal.pone.0072882
Gurung RL, Lim SN, Khaw AK et al (2010) Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells. PLoS ONE 5:e12124. https://doi.org/10.1371/journal.pone.0012124
Kolli-Bouhafs K, Boukhari A, Abusnina A, Velot E et al (2012) Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation. Invest New Drugs 30(6):2121–2131. https://doi.org/10.1007/s10637-011-9777-3
Khader M, Eckl PM (2014) Thymoquinone: an emerging natural drug with a wide range of medical applications. Iran J Basic Med Sci 17:950–957
Krex D, Klink B, Hartmann C et al (2007) Longterm survival with glioblastoma multiforme. Brain 130:2596–2606. https://doi.org/10.1093/brain/awm204
Pazhouhi M, Sariri R, Rabzia A, Khazaei M (2016) Thymoquinone synergistically potentiates temozolomide cytotoxicity through the inhibition of autophagy in U87MG cell line. Iran J Basic Med Sci 19:890–898
Gali-Muhtasib H, DiabAssaf M, Boltze C et al (2004) Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53dependent mechanism. Int J Oncol 25:857–866
Gali-Muhtasib H, Roessner A, SchneiderStock R (2006) Thymoquinone: a promising anticancer drug from natural sources. Int J Biochem Cell Biol 38:1249–1253
Chehl N, Chipitsyna G, Gong Q, Yeo CJ, Arafat HA (2009) Antiinflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford) 11(5):373–381. https://doi.org/10.1111/j.1477-2574.2009.00059.x
Roepke M, Diestel A, Bajbouj K et al (2007) Lack of p53 augments thymoquinone induced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biol Ther 6:160–169
Dastjerdi MN, Mehdiabady EM, Iranpour FG, Bahramian H (2016) Effect of thymoquinone on p53 gene expression and consequence apoptosis in breast cancer cell line. Int J Prev Med 7:66. https://doi.org/10.4103/2008-7802.180412
Hussain AR, Uddin S, Ahmed M et al (2013) Phosphorylated IkBa predicts poor prognosis in activated B-cell lymphoma and its inhibition with thymoquinone induces apoptosis via ROS release. PLoS ONE 8(3):e60540. https://doi.org/10.1371/journal.pone.0060540
Rahmani AH, Alzohairy MA, Khan MA, Aly SM (2014) Therapeutic implications of black seed and its constituent thymoquinone in the prevention of cancer through inactivation and activation of molecular pathways. Evid Based Complement Altern Med 2014:724658. https://doi.org/10.1155/2014/724658
Kato F, Tanaka M, Nakamura K (1999) Rapid fluorometric assay for cell viability and cell growth using nucleic acid staining and cell lysis agents. Toxicol In Vitro 13:923–929
Reers M, Smith TW, Chen LB (1991) J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30:4480–4486
Robinson KM, Janes MS, Pehar M et al (2006) Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. PNAS 103(41):15038–15043. https://doi.org/10.1073/pnas.0601945103
Gomes A, Fernandes E, Lima JL (2005) Fluorescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods 65:45–80. https://doi.org/10.1016/j.jbbm.2005.10.003
Wrona M, Wardman P (2006) Properties of the radical intermediate obtained on oxidation of 2′,7′-dichlorodihydrofluorescein, a probe for oxidative stress. Free Rad Biol Med 41:657–667. https://doi.org/10.1016/j.freeradbiomed.2006.05.006
Rice GC, Bump EA, Shrieve DC, Lee W, Kovacs M (1986) Quantitative analysis of cellular glutathione by flow cytometry using monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo. Cancer Res 46:6105–6110
Laurent A, Nicco C, Chereau C et al (2005) Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 65(3):948–956
Wondrak GT (2009) Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal 11(12):3013–3069. https://doi.org/10.1089/ARS.2009.2541
Rinaldi M, Caffo M, Minutoli L et al (2016) ROS and brain gliomas: an overview of potential and innovative therapeutic strategies. Int J Mol Sci 17(6):E984. https://doi.org/10.3390/ijms17060984
Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 8(7):579–591. https://doi.org/10.1038/nrd2803
Alhosin M, Abusnina A, Achour M et al (2010) Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1. Biochem Pharmacol 79(9):1251–1260. https://doi.org/10.1016/j.bcp.2009.12.015
Arafa E-SA, Zhu Q, Shah ZI et al (2011) Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Mutat Res 706(1–2):28–35. https://doi.org/10.1016/j.mrfmmm.2010.10.007
Paramasivam A, Raghunandhakumar S, Priyadharsini JV, Jayaraman G (2015) In vitro anti-neuroblastoma activity of thymoquinone against neuro-2a cells via cell-cycle arrest. Asian Pac J Cancer Prev 16(18):8313–8319
Banerjee S, Padhye S, Azmi A et al (2010) Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr Cancer 62(7):938–946. https://doi.org/10.1080/01635581.2010.509832
Rajput S, Kumar BN, Dey KK, Pal I, Parekh A, Mandal M (2013) Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells. Life Sci 93(21):783–790. https://doi.org/10.1016/j.lfs.2013.09.009
Woo CC, Hsu A, Kumar AP, Sethi G, Tan KH (2013) Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS. PLoS ONE 8(10):e75356. https://doi.org/10.1371/journal.pone.0075356
Yi T, Cho S-G, Yi Z et al (2008) Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and ERK signaling pathways. Mol Cancer Ther 7(7):1789–1796. https://doi.org/10.1158/1535-7163.MCT-08-0124
Salim LZ, Mohan S, Othman R et al (2013) Thymoquinone induces mitochondria-mediated apoptosis in acute lymphoblastic leukaemia in vitro. Molecules 18(9):11219–11240. https://doi.org/10.3390/molecules180911219
Hussain AR, Ahmed M, Ahmed S et al (2011) Thymoquinone suppresses growth and induces apoptosis via generation of reactive oxygen species in primary effusion lymphoma. Free Radic Biol Med 50:978–987. https://doi.org/10.1016/j.freeradbiomed.2010.12.034
Yu SM, Kim SJ (2013) Thymoquinone-induced reactive oxygen species causes apoptosis of chondrocytes via PI3K/Akt and p38kinase pathway. Exp Biol Med (Maywood) 238(7):811–820. https://doi.org/10.1177/1535370213492685
El-Najjar N, Chatila M, Moukadem H et al (2010) Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis 15:183–195. https://doi.org/10.1007/s10495-009-0421-z
Yu SM, Kim SJ (2015) The thymoquinone-induced production of reactive oxygen species promotes dedifferentiation through the ERK pathway and inflammation through the p38 and PI3K pathways in rabbit articular chondrocytes. Int J Mol Med 35(2):325–332. https://doi.org/10.3892/ijmm.2014.2014
Al-Shabanah OA, Badary OA, Nagi MN, Al-Gharably NM, Al-Rikabi AC, Al-Bekairi AM (1998) Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. J Exp Clin Cancer Res 17(2):193–198
Deller S, Macheroux P, Sollner S (2008) Flavin-dependent quinone reductases. Cell Mol Life Sci 65:141–160. https://doi.org/10.1007/s00018-007-7300-y
Siegel D, Reigan P, Ross D (2008) One- and two-electron-mediated reduction of quinones: enzymology and toxicological implications. In: Elfarra A (ed) Advances in bioactivation research. Springer-Verlag, New York, pp 169–199
Buffinton GD, Ollinger K, Brunmark A, Cadenas E (1989) DT-diaphorase-catalyzed reduction of 1,4-naphthoquinone derivatives and glutathionyl-quinone conjugates. Effect of substituents on autoxidation rates. Biochem J 257(2):561–571
Watanabe N, Forman HJ (2003) Autoxidation of extracellular hydroquinones is a causative event for the cytotoxicity of menadione and DMNQ in A549-S cells. Arch Biochem Biophys 411(1):145–157
Belinsky M, Jaiswal AK (1993) NAD(P)H: quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev 12:103–117
Kanamori M, Higa T, Sonoda Y et al (2015) Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients. Neuro-Oncology 17(4):555–565. https://doi.org/10.1093/neuonc/nou282
Backos DS, Franklin CC, Reigan P (2012) The role of glutathione in brain tumor drug resistance. Biochem Pharmacol 83(8):1005–1012. https://doi.org/10.1016/j.bcp.2011.11.016
Ollinger K, Kägedal K (2002) Induction of apoptosis by redox-cycling quinones. Subcell Biochem 36:151–170
Brunmark A, Cadenas E (1989) Redox and addition chemistry of quinoid compounds and its biological implications. Free Rad Biol Med 7:435–477
Guin PS, Das S, Mandal PC (2011) Electrochemical reduction of quinones in different media: a review. Intern J Electrochem 2011:816202. https://doi.org/10.4061/2011/816202
Khalife KH, Lupidi G (2007) Nonenzymatic reduction of thymoquinone in physiological conditions. Free Radic Res 41(2):153–161. https://doi.org/10.1080/10715760600978815
Kowaltowski AJ, Castilho RF, Vercesi AE (2001) Mitochondrial permeability transition and oxidative stress. FEBS Lett 495:12–15. https://doi.org/10.1016/S0014-5793(01)02316-X
Neuzil J, Dong LF, Rohlena J, Truksa J, Ralph SJ (2013) Classification of mitocans, anti-cancer drugs acting on mitochondria. Mitochondrion 13(3):199–208. https://doi.org/10.1016/j.mito.2012.07.112
Weinberg SE, Chandel NS (2015) Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol 11(1):9–15. https://doi.org/10.1038/nchembio.1712
Katsetos CD, Anni H, Dráber P (2013) Mitochondrial dysfunction in gliomas. Semin Pediatr Neurol 20(3):216–227. https://doi.org/10.1016/j.spen.2013.09.003
Sethi G, Ahn KS, Aggarwal BB (2008) Targeting nuclear factor-κB activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res 6(6):1059–1070. https://doi.org/10.1158/1541-7786.MCR-07-2088
Li F, Rajendran P, Sethi G (2010) Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway. Br J Pharmacol 161:541–554
Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P (2008) Redox regulation of cell survival. Antioxid Redox Signal 10(8):1343–1374. https://doi.org/10.1089/ars.2007.1957
Connelly L, Barham W, Onishko HM et al (2011) Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden. Oncogene 30:1402–1412. https://doi.org/10.1038/onc.2010.521
Xu D, Ma Y, Zhao B et al (2014) Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo. Oncol Rep 31(5):2063–2070. https://doi.org/10.3892/or.2014.3059
Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, González-Barón M (2004) PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30(2):193–204. https://doi.org/10.1016/j.ctrv.2003.07.007
Li X, Wu C, Chen N et al (2016) PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma. Oncotarget 7(22):33440–33450. https://doi.org/10.18632/oncotarget.7961
Jiang BH, Liu LZ (2008) Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. Drug Resist Updates 11(3):63–76. https://doi.org/10.1016/j.drup.2008.03.001
Chakravarti A, Zhai G, Suzuki Y et al (2004) The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol 22:1926–1933. https://doi.org/10.1200/JCO.2004.07.193
Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103(2):239–252
Wada T, Penninger JM (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23(16):2838–2849. https://doi.org/10.1038/sj.onc.1207556
Du L, Lyle CS, Obey TB et al (2004) Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent. J Biol Chem 279(12):11957–11966
Krylova NG, Kulahava TA, Koran SV, Semenkova GN (2017) Proliferation of cultured glioma cells mediated by coenzyme Q10 under conditions of serum deprivation. Cell Tissue Biol 11(3):220–226. https://doi.org/10.1134/S1990519X17030063
Acknowledgements
This study was supported by the research grant of the Belarusian Republican Foundation for Fundamental Research (M17M-092) and Belarusian Ministry of Education (the national program of scientific research number 20161385).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Krylova, N.G., Drobysh, M.S., Semenkova, G.N. et al. Cytotoxic and antiproliferative effects of thymoquinone on rat C6 glioma cells depend on oxidative stress. Mol Cell Biochem 462, 195–206 (2019). https://doi.org/10.1007/s11010-019-03622-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-019-03622-8